These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26788589)

  • 1. The emerging roles of liver X receptors and their ligands in cancer.
    Lin CY; Vedin LL; Steffensen KR
    Expert Opin Ther Targets; 2016; 20(1):61-71. PubMed ID: 26788589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting liver X receptors in cancer therapeutics.
    Lin CY; Gustafsson JÅ
    Nat Rev Cancer; 2015 Apr; 15(4):216-24. PubMed ID: 25786697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxysterol receptors and their therapeutic applications in cancer conditions.
    De Boussac H; Alioui A; Viennois E; Dufour J; Trousson A; Vega A; Guy L; Volle DH; Lobaccaro JM; Baron S
    Expert Opin Ther Targets; 2013 Sep; 17(9):1029-38. PubMed ID: 23875732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver X receptor as a drug target for the treatment of breast cancer.
    Wu Y; Yu DD; Yan DL; Hu Y; Chen D; Liu Y; Zhang HD; Yu SR; Cao HX; Feng JF
    Anticancer Drugs; 2016 Jun; 27(5):373-82. PubMed ID: 26872310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The liver X receptor: control of cellular lipid homeostasis and beyond Implications for drug design.
    Oosterveer MH; Grefhorst A; Groen AK; Kuipers F
    Prog Lipid Res; 2010 Oct; 49(4):343-52. PubMed ID: 20363253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting liver X receptors in inflammation.
    Steffensen KR; Jakobsson T; Gustafsson JÅ
    Expert Opin Ther Targets; 2013 Aug; 17(8):977-90. PubMed ID: 23738533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of Focused Compound Library Targeting Liver X Receptors in Pancreatic Cancer Identified Ligands with Inverse Agonist and Degrader Activity.
    Karaboga H; Huang W; Srivastava S; Widmann S; Addanki S; Gamage KT; Mazhar Z; Ebalunode JO; Briggs JM; Gustafsson JÅ; Filgueira CS; Gilbertson SR; Lin CY
    ACS Chem Biol; 2020 Nov; 15(11):2916-2928. PubMed ID: 33074669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers.
    Roshan-Moniri M; Hsing M; Butler MS; Cherkasov A; Rennie PS
    Cancer Treat Rev; 2014 Dec; 40(10):1137-52. PubMed ID: 25455729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting liver X receptors in human health: deadlock or promising trail?
    Viennois E; Pommier AJ; Mouzat K; Oumeddour A; El Hajjaji FZ; Dufour J; Caira F; Volle DH; Baron S; Lobaccaro JM
    Expert Opin Ther Targets; 2011 Feb; 15(2):219-32. PubMed ID: 21204733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanism of liver X receptors in cancer therapeutics.
    Wang Q; Wang J; Wang J; Zhang H
    Life Sci; 2021 May; 273():119287. PubMed ID: 33667512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver X receptor biology and pharmacology: new pathways, challenges and opportunities.
    Jakobsson T; Treuter E; Gustafsson JÅ; Steffensen KR
    Trends Pharmacol Sci; 2012 Jul; 33(7):394-404. PubMed ID: 22541735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory mechanism underlying liver X receptor effects on the tumor microenvironment, inflammation and tumorigenesis.
    Zhang H; Wang J; Sun J; Wang Q; Guo L; Ju X
    Expert Opin Ther Targets; 2023; 27(10):989-998. PubMed ID: 37753584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional crosstalk of CAR-LXR and ROR-LXR in drug metabolism and lipid metabolism.
    Xiao L; Xie X; Zhai Y
    Adv Drug Deliv Rev; 2010 Oct; 62(13):1316-21. PubMed ID: 20659512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer.
    Bovenga F; Sabbà C; Moschetta A
    Cell Metab; 2015 Apr; 21(4):517-26. PubMed ID: 25863245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver X receptors bridge hepatic lipid metabolism and inflammation.
    Liu Y; Qiu DK; Ma X
    J Dig Dis; 2012 Feb; 13(2):69-74. PubMed ID: 22257474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver X receptor: from metabolism to cancer.
    Venteclef N; Ferré P
    Biochem J; 2014 Apr; 459(2):e1-3. PubMed ID: 24678940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligands of Therapeutic Utility for the Liver X Receptors.
    Komati R; Spadoni D; Zheng S; Sridhar J; Riley KE; Wang G
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28067791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological roles of liver X receptors in immune cells.
    Pascual-García M; Valledor AF
    Arch Immunol Ther Exp (Warsz); 2012 Aug; 60(4):235-49. PubMed ID: 22696047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of liver X receptors in cardiac pathophysiology and heart failure.
    Cannon MV; van Gilst WH; de Boer RA
    Basic Res Cardiol; 2016 Jan; 111(1):3. PubMed ID: 26611207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action mechanisms of Liver X Receptors.
    Gabbi C; Warner M; Gustafsson JÅ
    Biochem Biophys Res Commun; 2014 Apr; 446(3):647-50. PubMed ID: 24300092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.